aarti drugs

7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

August 7, 2020

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20   Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…

Read More

Investing in beaten down Pharma in 2017-18 has given us two 30% + CAGR stocks

June 5, 2020

Dear Sir, If you have been reading our mails, you might be aware that we have been extensively focusing on beaten down stocks/sectors wherein the companies have strong balance sheets and will probably emerge stronger from this crisis. The thesis behind the same is simple: Since the bear market that started in Jan’18 and accentuated by covid-19 crisis, a lot of stocks have corrected to levels wherein the market is assuming that companies won’t survive. It is true that some…

Read More